Laura Williams
Chief Tech/Sci/R&D Officer chez ARDELYX, INC.
Fortune : 3 M $ au 31/03/2024
Postes actifs de Laura Williams
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ARDELYX, INC. | Chief Tech/Sci/R&D Officer | 01/01/2021 | - |
| Corporate Officer/Principal | 01/11/2020 | - |
Historique de carrière de Laura Williams
Anciens postes connus de Laura Williams
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 07/09/2017 | 01/01/2020 |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | 01/09/2016 | 01/08/2017 |
| IMARA | Director/Board Member | 30/06/2021 | - |
| Independent Dir/Board Member | 30/06/2021 | - |
Formation de Laura Williams
| University of Washington | Graduate Degree |
| Mississippi State University | Undergraduate Degree |
| University of Iowa | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARDELYX, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Imara, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies. The company was founded by James Gregg McArthur in 2016 and is headquartered in Brookline, MA. | Health Technology |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Health Technology |
- Bourse
- Insiders
- Laura Williams
- Expérience
